Overview
Medable offers a unified clinical trial platform designed to accelerate research, improve patient access, and ensure operational efficiency across decentralized, hybrid, and site-based studies. The platform leverages AI and a modular architecture to streamline data collection, enhance patient engagement, and reduce trial timelines. Key components include Studio for rapid study building, AI agents for automating Trial Master File (TMF) processes, eCOA for real-time patient-reported data, eConsent, remote monitoring, and connected sensors. Medable's cloud-agnostic, single API platform supports self-service build and system integrations, facilitating scalability across over 60 countries and 120 languages. The platform aims to eliminate clinical trial 'white space' through AI-driven automation, addressing the limits of human-only clinical development and accelerating drug development timelines.